Papers

1

Total Citations

39

H-Index

1

About

Kurtis Berry is a neuroscientist whose research focuses on the molecular pharmacology of metabotropic glutamate receptors (mGluRs), critical targets for treating neurological and psychiatric disorders. His most influential work, "Identification of metabotropic glutamate receptor antagonists using an automated high-throughput screening system" (2003, 39 citations), pioneered the integration of automated screening technologies to rapidly identify selective mGluR antagonists. This contribution advanced drug discovery by enabling efficient, large-scale evaluation of compound libraries, accelerating the search for novel therapeutics for conditions such as anxiety, schizophrenia, and chronic pain. Berry’s approach demonstrated how combining robotics with pharmacological assays could yield reproducible, high-quality data, setting a standard for future high-throughput screening in neuropharmacology. His work remains a foundational reference for researchers developing targeted mGluR modulators, reflecting his impact on both basic neuroscience and translational drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
39
Total Citations
39
Avg Citations/Paper
🏆 Most Cited Paper
Identification of metabotropic glutamate receptor antagonists using an automated high-throughput screening system
39 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago